Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity

Serum testosterone does not correlate with androgen tissue activity, and it is critical to optimize tools to evaluate such activity in males. Ultrasound measurement of bulbocavernosus muscle (BCM) was used to assess the relationship between the number of CAG repeats (CAGn) in the androgen receptor (...

Full description

Bibliographic Details
Main Authors: Ali A Dabaja, Matthew S Wosnitzer, Anna Mielnik, Alexander Bolyakov, Peter N Schlegel, Darius A Paduch
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-08-01
Series:Asian Journal of Andrology
Subjects:
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=618;epage=622;aulast=Dabaja
id doaj-1dbc88f57a4e47d7b44445ce4bc185b0
record_format Article
spelling doaj-1dbc88f57a4e47d7b44445ce4bc185b02020-11-25T00:38:12ZengWolters Kluwer Medknow PublicationsAsian Journal of Andrology1008-682X1745-72622014-08-0116461862210.4103/1008-682X.123681Bulbocavernosus muscle area measurement: a novel method to assess androgenic activityAli A DabajaMatthew S WosnitzerAnna MielnikAlexander BolyakovPeter N Schlegel Darius A PaduchSerum testosterone does not correlate with androgen tissue activity, and it is critical to optimize tools to evaluate such activity in males. Ultrasound measurement of bulbocavernosus muscle (BCM) was used to assess the relationship between the number of CAG repeats (CAGn) in the androgen receptor (AR) and the BCM size; the changes in the number of CAGn over age were also evaluated. Transperineal ultrasound measurement of the BCM was also performed. AR CAGn were determined by high performance liquid chromatography, and morning hormone levels were determined using immunoassays. Forty-eight men had CAG repeat analysis. Twenty-five were <30 years of age, mean 23.7 years (s.d. = 3.24) and 23 were >45 years of age, mean 53 years (s.d. = 5.58). The median CAGn was 21 (13-29). BCM area was greater when the number of CAGn were <18 as compared to the number of CAGn >24 (P = 0.04). There was a linear correlation between the number of CAGn and the BCM area R 2 = 16% (P = 0.01). In the 45 to 65-years-old group, a much stronger negative correlation (R 2 = 29%, P = 0.01) was noticed. In the 19 to 29-years-old group, no such correlation was found (R 2 = 4%, P = 0.36). In older men, the number of CAGn increased with age (R 2 = 32%, P = 0.01). The number of CAGn in the AR correlates with the area of the BCM. Ultrasound assessment of the BCM is an effective surrogate to evaluate end-organ activity of androgens. The number of CAGn may increase with age.http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=618;epage=622;aulast=Dabajaage; androgen activity; androgen receptor; androgen sensitivity; bulbocavernosus muscle; CAG repeats
collection DOAJ
language English
format Article
sources DOAJ
author Ali A Dabaja
Matthew S Wosnitzer
Anna Mielnik
Alexander Bolyakov
Peter N Schlegel
Darius A Paduch
spellingShingle Ali A Dabaja
Matthew S Wosnitzer
Anna Mielnik
Alexander Bolyakov
Peter N Schlegel
Darius A Paduch
Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity
Asian Journal of Andrology
age; androgen activity; androgen receptor; androgen sensitivity; bulbocavernosus muscle; CAG repeats
author_facet Ali A Dabaja
Matthew S Wosnitzer
Anna Mielnik
Alexander Bolyakov
Peter N Schlegel
Darius A Paduch
author_sort Ali A Dabaja
title Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity
title_short Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity
title_full Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity
title_fullStr Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity
title_full_unstemmed Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity
title_sort bulbocavernosus muscle area measurement: a novel method to assess androgenic activity
publisher Wolters Kluwer Medknow Publications
series Asian Journal of Andrology
issn 1008-682X
1745-7262
publishDate 2014-08-01
description Serum testosterone does not correlate with androgen tissue activity, and it is critical to optimize tools to evaluate such activity in males. Ultrasound measurement of bulbocavernosus muscle (BCM) was used to assess the relationship between the number of CAG repeats (CAGn) in the androgen receptor (AR) and the BCM size; the changes in the number of CAGn over age were also evaluated. Transperineal ultrasound measurement of the BCM was also performed. AR CAGn were determined by high performance liquid chromatography, and morning hormone levels were determined using immunoassays. Forty-eight men had CAG repeat analysis. Twenty-five were <30 years of age, mean 23.7 years (s.d. = 3.24) and 23 were >45 years of age, mean 53 years (s.d. = 5.58). The median CAGn was 21 (13-29). BCM area was greater when the number of CAGn were <18 as compared to the number of CAGn >24 (P = 0.04). There was a linear correlation between the number of CAGn and the BCM area R 2 = 16% (P = 0.01). In the 45 to 65-years-old group, a much stronger negative correlation (R 2 = 29%, P = 0.01) was noticed. In the 19 to 29-years-old group, no such correlation was found (R 2 = 4%, P = 0.36). In older men, the number of CAGn increased with age (R 2 = 32%, P = 0.01). The number of CAGn in the AR correlates with the area of the BCM. Ultrasound assessment of the BCM is an effective surrogate to evaluate end-organ activity of androgens. The number of CAGn may increase with age.
topic age; androgen activity; androgen receptor; androgen sensitivity; bulbocavernosus muscle; CAG repeats
url http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=618;epage=622;aulast=Dabaja
work_keys_str_mv AT aliadabaja bulbocavernosusmuscleareameasurementanovelmethodtoassessandrogenicactivity
AT matthewswosnitzer bulbocavernosusmuscleareameasurementanovelmethodtoassessandrogenicactivity
AT annamielnik bulbocavernosusmuscleareameasurementanovelmethodtoassessandrogenicactivity
AT alexanderbolyakov bulbocavernosusmuscleareameasurementanovelmethodtoassessandrogenicactivity
AT peternschlegel bulbocavernosusmuscleareameasurementanovelmethodtoassessandrogenicactivity
AT dariusapaduch bulbocavernosusmuscleareameasurementanovelmethodtoassessandrogenicactivity
_version_ 1725298419297157120